By Josh White
Date: Monday 07 Oct 2024
LONDON (ShareCast) - (Sharecast News) - Futura Medical, the consumer healthcare company behind Eroxon, announced on Monday that a $5m milestone payment had been triggered under its agreement with consumer products giant Haleon.
The AIM-traded firm said the milestone followed the successful distribution of online pre-orders and the availability of Eroxon in US retail stores.
It said the payment was expected to be received shortly.
Eroxon, Futura's flagship product, is a clinically-proven sexual health product.
The milestone payment was another key step in its ongoing strategy to commercialise its products globally, with the US launch being a major milestone in the product's growth.
At 1356 BST, shares in Futura Medical were up 2.77% at 33.45p.
Reporting by Josh White for Sharecast.com.
Email this article to a friend
or share it with one of these popular networks:
Currency | UK Pounds |
Share Price | 362.90p |
Change Today | 2.90p |
% Change | 0.81 % |
52 Week High | 415.20p |
52 Week Low | 348.10p |
Volume | 15,334,714 |
Shares Issued | 8,957m |
Market Cap | £32,506m |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Latest | Previous | |
---|---|---|
Interim | Final | |
Ex-Div | 14-Aug-25 | 24-Apr-25 |
Paid | 18-Sep-25 | 05-Jun-25 |
Amount | 2.20p | 4.60p |
Time | Volume / Share Price |
16:47 | 90,761 @ 363.17p |
16:35 | 2,446 @ 362.90p |
16:35 | 116,021 @ 362.90p |
16:35 | 3,765 @ 362.90p |
16:35 | 23,805 @ 362.90p |
You are here: research